Form EFFECT Pyxis Oncology, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 27, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
- BRC Group Holdings, Inc. Announces Full Redemption of 6.50% Senior Notes Due 2026
- Lotto.com Joins the World Series of Golf Satellite Series as Official Lottery Courier Partner
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share